These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4931698

  • 1. [Limits of immunosuppressive therapy].
    Götz H.
    Munch Med Wochenschr; 1971 Jun 04; 113(23):906. PubMed ID: 4931698
    [No Abstract] [Full Text] [Related]

  • 2. Complications of immunosuppressive therapy in transplantation. 2: Specific immunosuppressive agents.
    Russ GR.
    Med J Aust; 1992 Aug 17; 157(4):264-7. PubMed ID: 1435444
    [No Abstract] [Full Text] [Related]

  • 3. Complications of immunosuppression.
    Penn I.
    Minerva Chir; 1971 Jul 15; 26(13):718-20. PubMed ID: 5567243
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Current status of immunosuppression].
    Kaspar F.
    Dtsch Med J; 1968 Apr 05; 19(7):211-3. PubMed ID: 4180292
    [No Abstract] [Full Text] [Related]

  • 6. [Late complications caused by immunosuppressive therapy in kidney transplantation].
    Albrechtsen D.
    Tidsskr Nor Laegeforen; 1979 Mar 10; 99(7):370-3. PubMed ID: 373159
    [No Abstract] [Full Text] [Related]

  • 7. [Polyomavirus and tubulointerstitial nephropathy].
    Antoine C, Hill G, Glotz D, Fontanière B, Tabone E, Nochy D.
    Nephrologie; 2001 Mar 10; 22(6):317-20. PubMed ID: 11715610
    [No Abstract] [Full Text] [Related]

  • 8. Perspectives of immunosuppression.
    Balner H.
    Transplant Proc; 1971 Mar 10; 3(1):949-52. PubMed ID: 4941149
    [No Abstract] [Full Text] [Related]

  • 9. [Immune tolerance and antilymphocyte sera].
    Kaden J.
    Z Arztl Fortbild (Jena); 1971 May 15; 65(9-10):522-8. PubMed ID: 5000438
    [No Abstract] [Full Text] [Related]

  • 10. [Immunosuppression, tumoricidal agents and carcinogenesis].
    Gorin NC.
    Nouv Presse Med; 1981 May 09; 10(21):1699-702. PubMed ID: 7015273
    [No Abstract] [Full Text] [Related]

  • 11. Malignancy after immunosuppressive therapy.
    Mazzei D, Polli EE, Quarto di Palo F.
    Boll Ist Sieroter Milan; 1977 Mar 31; 56(2):197. PubMed ID: 326275
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy with organ transplantation: actual possibilities and future prospects. I].
    Cairella M.
    Clin Ter; 1971 Apr 15; 57(1):63-92. PubMed ID: 4933050
    [No Abstract] [Full Text] [Related]

  • 13. [Experimental lung transplantation. Immunosuppressive therapy].
    Morino F, Olivero S, Vezzosi E, Bezzi P, Ibba F, Gallingani R, Sanfelici G.
    Minerva Med; 1969 Mar 14; 60(21):903-17. PubMed ID: 4888328
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
    Luciani J, Benalia H, Bitker MO, Mouquet C, Chartier-Kastler E, Ourhama S, Jacobs C, Chatelain C, Viars P.
    Transplant Proc; 1993 Jun 14; 25(3):2302. PubMed ID: 8516907
    [No Abstract] [Full Text] [Related]

  • 16. Immunosuppression and its complications.
    Woodruff M.
    Proc R Soc Med; 1969 Apr 14; 62(4):411-6. PubMed ID: 4897833
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Ocular zona and herpes in patients under immunosuppressive agents. Apropos of 9 cases].
    Lagoutte F, Campagne JC, Monroy J, Le Rebeller MJ.
    Bull Soc Ophtalmol Fr; 1980 Mar 14; 80(3):289-90. PubMed ID: 6965894
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The immunology of transplantation.
    Lawrence HS.
    Transplant Proc; 1969 Mar 14; 1(1):645-8. PubMed ID: 4109232
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.